Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

COVID-19 Resurgence In China To Hurt Tesla, Chinese Automakers: Which EV Stock Is Likely To Suffer The Most?

Published 17/03/2022, 14:40
© Reuters COVID-19 Resurgence In China To Hurt Tesla, Chinese Automakers: Which EV Stock Is Likely To Suffer The Most?
TSLA
-
SSEC
-
GIG
-
CHNA
-

It's déjà vu all over again, as China reported a renewed outbreak of COVID-19, forcing new lockdowns primarily in the northeastern regions of the country.

As the nation grapples with the worst outbreak in two years, here's a look at how EV makers and their production plans and sales will be impacted.

Nio Has The Highest Exposure Among EV Makers: New COVID-19 cases are soaring to more than 3,000 per day in China, with Jilin, Shandong, Guangdong and Shanghai having been the worst affected, Bernstein analyst Eunice Lee said in a note. The governments in these provinces have imposed various degrees of lockdown, the analyst noted.

State-owned automaker GAC, Nio Inc - ADR (NYSE: NIO) and General Motor Company's (NYSE: GM) Chinese joint venture partner SAIC Motor Corporation have more direct volume exposure to COVID-19 impacted regions, the analyst said.

GAC's manufacturing base produces Chinese market versions of cars by Japanese automakers such as Toyota Motor Corp (NYSE: TM) and Honda Motor Co. Ltd. (NYSE: HMC).

The Jilin, Shandong and Guangdong provinces and Shanghai together accounted for 26% of China's auto sales and 32% of EV sales by volume in 2021, Lee said.

Among EV makers, Nio has the highest exposure to these four regions, the analyst said. Nio's 42% exposure is higher than the 36% for Tesla Inc (NASDAQ: TSLA), 26% for XPeng Inc - ADR (NYSE: XPEV) and 23% for Li Auto Inc. (NASDAQ: LI), she added.

Taking into account the ICE (NYSE:ICE) (internal-combustion engine) companies, the four affected regions account for 37% of GAC's passenger vehicle sales volume, 33% of GAC Honda's volume and 30% of GAC Toyota's volume, Lee said. The analyst also noted that SAIC has 26% exposure.

Related Link: Raw Material Shortages May Not Be Hurting Tesla Right Now, But This Other Shortfall Might

Why It's Important: The return of COVID-19 in China, despite the strict protocols followed by local administrations, comes at a time when the world is limping back to normalcy from the impact of the novel coronavirus that first appeared in China in late 2019 and then emerged as a pan-global crisis.

Additionally, the world economy is currently facing multiple shocks, including monetary policy normalizations by major central banks and the Ukraine-Russia war.

In response to the fresh outbreak in China, Tesla reportedly shuttered production at its Giga Shanghai for two days.

More information on the potential impact could emerge over the coming weeks when the U.S.-listed Chinese EV makers report their financial results.

Related Link: Nio Reverses Course After Sell-Off: Will EV Stock Rally Ahead Of Earnings?

Photos: Courtesy Tesla, Xpeng (NYSE:XPEV) (top row), Li Auto and Nio (bottom row)

Latest Ratings for TSLA

DateFirmActionFromTo
Feb 2022Daiwa CapitalUpgradesNeutralOutperform
Feb 2022Piper SandlerMaintainsOverweight
Jan 2022 Credit Suisse (SIX:CSGN)UpgradesNeutralOutperform
View More Analyst Ratings for TSLA

View the Latest Analyst Ratings

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.